Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Insite Vision Inc. -- Ignore unavailable to you. Want to Upgrade?

To: David Bogdanoff who wrote (542)	11/17/1997 10:26:00 AM
From: Robert Mayo	Read Replies (1) \| Respond to of 1060

David, Certainly the potential is there for Insite to become a big winner. Although recent analyst estimates are hard to come by, INSVs product portfolio is probably worth over $250 million. The company has a market cap of about one quarter of that. I don't see how the stock will ever hit Murphy's price target of $30, but something in the high teens looks "doable." We'll see. Mike Baer met with a First Boston analyst a couple of weeks ago. Maybe a research report will be forthcoming. I'll keep trying to get my hands on something solid, and post anything I find. Bob